IFIT1, IFIT2, IFIT3, and IFIT5 are overexpressed in acute myeloid leukemia (AML) patients, with higher levels of IFIT2, IFIT3, and IFIT5 predicting poor prognosis 51. Here, IFIT2 is linked to acute myeloid leukemia.